Antidiabetic spiro-3-heteroazolidines
US4740517A · kind A · utility
10Cited by
1References
20Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 3, 1986 |
| Grant date | Apr 26, 1988 |
| Priority date | — |
| Expiry date | Mar 3, 2006 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D513/10
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A spiro-3-heteroazolidine compound and agents comprising that compound which have special utility as an antidiabetic composition and as a substance to inhibit aldose reductase enzyme activity.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.